Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9N0Y

PP2A-B55 Holoenzyme with Eya3

Summary for 9N0Y
Entry DOI10.2210/pdb9n0y/pdb
EMDB information48798
DescriptorSerine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform, Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform, Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, ... (4 entities in total)
Functional Keywordsser/thr phosphatase, complex, myc stabilization, oncoprotein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains4
Total formula weight215413.99
Authors
Shi, S.,Li, X.,Alderman, C.,Zhao, R. (deposition date: 2025-01-24, release date: 2025-06-18, Last modification date: 2025-07-09)
Primary citationShi, S.,Li, X.,Alderman, C.,Wick, L.,Huang, W.,Foulon, N.,Zhang, L.,Rossi, J.,Hu, W.,Cui, S.,Zheng, H.,Taylor, D.J.,Ford, H.L.,Zhao, R.
Cryo-EM structures reveal the PP2A-B55 alpha and Eya3 interaction that can be disrupted by a peptide inhibitor.
J.Biol.Chem., 301:110287-110287, 2025
Cited by
PubMed Abstract: We have previously shown that Eya3 recruits PP2A-B55α to dephosphorylate pT58 on Myc, increasing Myc stability and enhancing primary tumor growth of triple-negative breast cancer (TNBC). However, the molecular details of how Eya3 recruits PP2A-B55α remain unclear. Here, we determined the cryo-EM structures of PP2A-B55α bound with Eya3, with an inhibitory peptide B55i, and in its unbound state. These studies demonstrate that Eya3 binds B55α through an extended peptide in the N-terminal domain of Eya3. The Eya3 peptide, PP2A-B55α substrates, and protein-peptide inhibitors including B55i bind to a similar area on the B55α surface, but the molecular details of the binding differ. We further demonstrated that the B55i peptide inhibits the B55α and Eya3 interaction in vitro. The B55i peptide expressed on a plasmid increases Myc pT58 and decreases Myc protein levels in TNBC cells, suggesting the potential of B55i or similar peptides as therapies for TNBC.
PubMed: 40414499
DOI: 10.1016/j.jbc.2025.110287
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.71 Å)
Structure validation

248335

PDB entries from 2026-01-28

PDB statisticsPDBj update infoContact PDBjnumon